EE78 A Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment Following Complete Resection and Platinum-Based Chemotherapy in Adult Patients With Early-Stage Non-Small Cell Lung Cancer With a High Risk of Recurrence

Abstract

Authors

L. Silva Miguel B. Pinheiro P. Carvalho N. Jovanoski R. Belleli S. Abogunrin P. Alves A. Araújo F. Barata V. Hespanhol R. da Luz M. Borges